SKI Market

A+| A| A-|

Indian Indices

Sensex

75,273.45 0.00
( 0.00%)

Global Indices

Nasdaq

45,986.51 -463.99
(-1.00%)

Dow Jones

6,496.71 -116.19
(-1.76%)

Hang Seng

53,366.12 -383.50
(-0.71%)

Nikkei 225

9,975.43 -131.41
(-1.30%)

Forex

USD-INR

93.86 0.07
(0.08%)

EUR-INR

108.76 0.06
(0.06%)

GBP-INR

125.66 0.01
(0.01%)

JPY-INR

0.59 0.00
(-0.13%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Lal Pathlabs Ltd

Industry : Healthcare

BSE Code

ISIN Demat

Book Value()

539524

INE600L01024

139.7140778

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LALPATHLAB

42.08

22577.2

EPS(TTM)

Face Value()

Div & Yield %

32.02

0.89

Back

XPRO India standalone net profit declines 45.89% in the September 2025 quarter

Nov 06,2025

Net profit of XPRO India declined 45.89% to Rs 5.86 crore in the quarter ended September 2025 as against Rs 10.83 crore during the previous quarter ended September 2024. Sales declined 10.50% to Rs 119.91 crore in the quarter ended September 2025 as against Rs 133.98 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	119.91	133.98	-11
OPM %	5.99	10.08	-
PBDT	10.42	17.26	-40
PBT	7.59	14.61	-48
NP	5.86	10.83	-46

75,273.45 0.00 ( 0.00%)

45,986.51 -463.99 (-1.00%)

6,496.71 -116.19 (-1.76%)

53,366.12 -383.50 (-0.71%)

9,975.43 -131.41 (-1.30%)

93.86 0.07 (0.08%)

108.76 0.06 (0.06%)

125.66 0.01 (0.01%)

0.59 0.00 (-0.13%)